Mitoxantrone Sandoz 2 mg/ml inf. opl. (conc.) i.v. flac. Belgicko - holandčina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mitoxantrone sandoz 2 mg/ml inf. opl. (conc.) i.v. flac.

sandoz sa-nv - mitoxantronhydrochloride 2,33 mg/ml - eq. mitoxantron 2 mg/ml - concentraat voor oplossing voor infusie - 2 mg/ml - mitoxantronhydrochloride 2.33 mg/ml - mitoxantrone

Doxolipad Európska únia - holandčina - EMA (European Medicines Agency)

doxolipad

tlc biopharmaceuticals b.v. - doxorubicine hydrochloride - breast neoplasms; ovarian neoplasms - antineoplastische middelen - behandeling van borst-en eierstokkanker.

Epirubicin Hikma 2 mg/ml i.vesic. opl./inj. opl. i.v. flac. Belgicko - holandčina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

epirubicin hikma 2 mg/ml i.vesic. opl./inj. opl. i.v. flac.

hikma farmacêutica s.a. - epirubicinehydrochloride 2 mg/ml - oplossing voor intravesicaal gebruik/oplossing voor injectie - 2 mg/ml - epirubicinehydrochloride 2 mg/ml - epirubicin

Epirubicin Hikma 2 mg/ml i.vesic. opl./inj. opl. i.v. flac. Belgicko - holandčina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

epirubicin hikma 2 mg/ml i.vesic. opl./inj. opl. i.v. flac.

hikma farmacêutica s.a. - epirubicinehydrochloride 2 mg/ml - oplossing voor intravesicaal gebruik/oplossing voor injectie - 2 mg/ml - epirubicinehydrochloride 2 mg/ml - epirubicin

Epirubicin Hikma 2 mg/ml i.vesic. opl./inj. opl. i.v. flac. Belgicko - holandčina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

epirubicin hikma 2 mg/ml i.vesic. opl./inj. opl. i.v. flac.

hikma farmacêutica s.a. - epirubicinehydrochloride 2 mg/ml - oplossing voor intravesicaal gebruik/oplossing voor injectie - 2 mg/ml - epirubicinehydrochloride 2 mg/ml - epirubicin

Epirubicin Hikma 2 mg/ml i.vesic. opl./inj. opl. i.v. flac. Belgicko - holandčina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

epirubicin hikma 2 mg/ml i.vesic. opl./inj. opl. i.v. flac.

hikma farmacêutica s.a. - epirubicinehydrochloride 2 mg/ml - oplossing voor intravesicaal gebruik/oplossing voor injectie - 2 mg/ml - epirubicinehydrochloride 2 mg/ml - epirubicin

Zolsketil pegylated liposomal Európska únia - holandčina - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Zavedos 10 mg harde caps. Belgicko - holandčina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zavedos 10 mg harde caps.

pfizer sa-nv - idarubicinehydrochloride 10 mg - capsule, hard - idarubicin

Zavedos 10 mg inj. opl. (pdr.) i.v. flac. Belgicko - holandčina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zavedos 10 mg inj. opl. (pdr.) i.v. flac.

pfizer sa-nv - idarubicinehydrochloride 10 mg - poeder voor oplossing voor injectie - idarubicin

Zavedos 25 mg harde caps. Belgicko - holandčina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zavedos 25 mg harde caps.

pfizer sa-nv - idarubicinehydrochloride 25 mg - capsule, hard - idarubicin